ArticleInvestigational new drugs2018

Phase I study of the combination of quinacrine and erlotinib in patients with locally advanced or metastatic non small cell lung cancer.

Priyanka Bhateja et al.PubMed ↗Publisher ↗

No numbers read from the abstract.